Table 1.
Association between miR-153 expression and clinical and pathological characteristics of patients with prostate cancer.
Variables | Cases (n) | MiR-153 expression |
P-value | |
---|---|---|---|---|
High (n = 31) | Low (n = 30) | |||
Age, years | ||||
<55 | 15 | 9 | 6 | 0.818 |
≥55 | 46 | 24 | 22 | |
Lymph node metastasis | ||||
Yes | 29 | 22 | 7 | 0.180 |
No | 32 | 18 | 14 | |
Bone metastases | ||||
Yes | 27 | 18 | 9 | 0.203 |
No | 34 | 16 | 18 | |
Gleason score | ||||
<8 | 23 | 12 | 11 | 0.710 |
≥8 | 38 | 23 | 15 | |
TNM stage | ||||
I + II | 32 | 8 | 24 | 0.001 |
IV | 29 | 23 | 6 |
TNM, tumor, node, metastasis.